Physician profile
Uwe Blecker
NPI 1225013527
$351.13
in general payments reported to CMS, 2019-2025
11 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.94 · 2021: $24.78 · 2023: $41.33 · 2024: $62.09 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $150.00 | 2025 | |
| Novo Nordisk INC | $44.38 | 2024 | Sogroya |
| Abbvie INC. | $38.72 | 2020-2021 | |
| Ipsen Biopharmaceuticals, INC | $22.92 | 2023 | Bylvay |
| Sanofi-Aventis U.S. LLC | $22.07 | 2025 | |
| Alcresta Therapeutics, INC. | $19.63 | 2025 | Relizorb |
| Regeneron Healthcare Solutions, INC. | $18.41 | 2023 | Dupixent |
| Ucb, INC. | $17.71 | 2024 | Bimzelx |
| Kyowa Kirin, INC. | $17.29 | 2025 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uwe Blecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.